文献速递慢性肾脏病肾血管病与高血压

维生素D治疗减轻尿毒症大鼠心脏FGF23/FGFR4信号与心肌肥厚

Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

在5/6肾切除尿毒症大鼠中,骨与心肌FGF23表达升高、心脏FGFR4表达及钙调神经磷酸酶/NFAT激活增加,且与左心室肥厚相关。骨化三醇治疗减轻左心室肥厚及心脏FGFR4表达和钙调神经磷酸酶/NFAT激活,高剂量骨化三醇抑制心脏完整FGF23蛋白水平。体外共处理骨化三醇阻断FGF23诱导的FGFR4激活和心肌细胞肥大性生长。

要点

  • 尿毒症大鼠心脏FGF23/FGFR4表达及钙调神经磷酸酶/NFAT激活升高,与左心室肥厚相关。
  • 骨化三醇减轻尿毒症大鼠左心室肥厚及心脏FGFR4表达和钙调神经磷酸酶/NFAT激活。
  • 体外骨化三醇阻断FGF23诱导的心肌细胞FGFR4激活和肥大性生长。

核心结论

  • 作者认为在慢性肾脏病中,骨化三醇的心脏保护作用源于其对心脏FGF23/FGFR4系统的抑制作用,高FGF23和低骨化三醇对心肌细胞的反向平衡效应协同促进心肌肥厚。

研究设计与样本

  • 研究对5/6肾切除(5/6 Nx)大鼠给予不同剂量骨化三醇治疗4周或10周,分析心脏FGF23/FGFR4表达、钙调神经磷酸酶/NFAT激活及左心室肥厚。
  • 体外研究在培养的心肌细胞中联合给予FGF23和骨化三醇,观察FGFR4激活与肥大性细胞生长。

主要发现

  • 在伴左心室肥厚的5/6 Nx大鼠中,骨与心肌FGF23表达升高,心脏FGFR4表达增加,心脏钙调神经磷酸酶/NFAT信号激活升高。
  • 尿毒症大鼠心脏FGF23和FGFR4表达水平与左心室肥厚的存在显著相关。
  • 骨化三醇治疗减轻左心室肥厚,并降低心脏FGFR4表达和钙调神经磷酸酶/NFAT激活。
  • 骨化三醇以剂量依赖方式进一步刺激骨与心脏FGF23表达,但高剂量骨化三醇抑制心脏完整FGF23蛋白水平。
  • 在培养的心肌细胞中,骨化三醇共处理阻断FGF23诱导的FGFR4激活和肥大性细胞生长。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vitamin D deficiency and excess of circulating fibroblast growth factor 23 (FGF23) contribute to cardiovascular mortality in patients with chronic kidney disease (CKD). FGF23 activates FGF receptor 4 and (FGFR4) calcineurin/nuclear factor of activated T cells (NFAT) signaling in cardiac myocytes, thereby causing left ventricular hypertrophy (LVH). Here, we determined if 1,25-dihydroxyvitamin D (calcitriol) inhibits FGF23-induced cardiac signaling and LVH. METHODS: 5/6 nephrectomized (5/6 Nx) rats were treated with different doses of calcitriol for 4 or 10 weeks and cardiac expression of FGF23/FGFR4 and activation of calcineurin/NFAT as well as LVH were analyzed. FGFR4 activation and hypertrophic cell growth were studied in cultured cardiac myocytes that were co-treated with FGF23 and calcitriol. RESULTS: In 5/6Nx rats with LVH, we detected elevated FGF23 expression in bone and myocardium, increased cardiac expression of FGFR4 and elevated cardiac activation of calcineurin/NFAT signaling. Cardiac expression levels of FGF23 and FGFR4 significantly correlated with the presence of LVH in uremic rats. Treatment with calcitriol reduced LVH as well as cardiac FGFR4 expression and calcineurin/NFAT activation. Bone and cardiac FGF23 expression were further stimulated by calcitriol in a dose-dependent manner, but levels of intact cardiac FGF23 protein were suppressed by high-dose calcitriol. In cultured cardiac myocytes, co-treatment with calcitriol blocked FGF23-induced activation of FGFR4 and hypertrophic cell growth. CONCLUSIONS: Our data suggest that in CKD, cardioprotective effects of calcitriol stem from its inhibitory actions on the cardiac FGF23/FGFR4 system, and based on their counterbalancing effects on cardiac myocytes, high FGF23 and low calcitriol synergistically contribute to cardiac hypertrophy.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Leifheit-Nestler M, Grabner A, Hermann L, et al. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats. Nephrol Dial Transplant. 2017. PMID: 28339837. doi:10.1093/ndt/gfw454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。